IBDEI04Z ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2026,1,5,0)
 ;;=5^CHR ISCHEMIC HRT DIS NOS
 ;;^UTILITY(U,$J,358.3,2026,2)
 ;;=^24401
 ;;^UTILITY(U,$J,358.3,2027,0)
 ;;=349.9^^21^183^9
 ;;^UTILITY(U,$J,358.3,2027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2027,1,4,0)
 ;;=4^349.9
 ;;^UTILITY(U,$J,358.3,2027,1,5,0)
 ;;=5^CNS DISORDER NOS
 ;;^UTILITY(U,$J,358.3,2027,2)
 ;;=^123890
 ;;^UTILITY(U,$J,358.3,2028,0)
 ;;=412.^^21^183^17
 ;;^UTILITY(U,$J,358.3,2028,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2028,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,2028,1,5,0)
 ;;=5^OLD MYOCARDIAL INFARCT
 ;;^UTILITY(U,$J,358.3,2028,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,2029,0)
 ;;=427.89^^21^183^20
 ;;^UTILITY(U,$J,358.3,2029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2029,1,4,0)
 ;;=4^427.89
 ;;^UTILITY(U,$J,358.3,2029,1,5,0)
 ;;=5^Rhythm Disorder
 ;;^UTILITY(U,$J,358.3,2029,2)
 ;;=^87896
 ;;^UTILITY(U,$J,358.3,2030,0)
 ;;=785.0^^21^183^26
 ;;^UTILITY(U,$J,358.3,2030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2030,1,4,0)
 ;;=4^785.0
 ;;^UTILITY(U,$J,358.3,2030,1,5,0)
 ;;=5^Tachycardia NOS
 ;;^UTILITY(U,$J,358.3,2030,2)
 ;;=^117041
 ;;^UTILITY(U,$J,358.3,2031,0)
 ;;=277.6^^21^184^1
 ;;^UTILITY(U,$J,358.3,2031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2031,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,2031,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,2031,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,2032,0)
 ;;=494.0^^21^184^5
 ;;^UTILITY(U,$J,358.3,2032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2032,1,4,0)
 ;;=4^494.0
 ;;^UTILITY(U,$J,358.3,2032,1,5,0)
 ;;=5^Bronchiectasis, chronic
 ;;^UTILITY(U,$J,358.3,2032,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,2033,0)
 ;;=496.^^21^184^7
 ;;^UTILITY(U,$J,358.3,2033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2033,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,2033,1,5,0)
 ;;=5^COPD, General
 ;;^UTILITY(U,$J,358.3,2033,2)
 ;;=COPD, General^24355
 ;;^UTILITY(U,$J,358.3,2034,0)
 ;;=786.2^^21^184^8
 ;;^UTILITY(U,$J,358.3,2034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2034,1,4,0)
 ;;=4^786.2
 ;;^UTILITY(U,$J,358.3,2034,1,5,0)
 ;;=5^Cough
 ;;^UTILITY(U,$J,358.3,2034,2)
 ;;=Cough^28905
 ;;^UTILITY(U,$J,358.3,2035,0)
 ;;=786.09^^21^184^9
 ;;^UTILITY(U,$J,358.3,2035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2035,1,4,0)
 ;;=4^786.09
 ;;^UTILITY(U,$J,358.3,2035,1,5,0)
 ;;=5^Dyspnea
 ;;^UTILITY(U,$J,358.3,2035,2)
 ;;=Dyspnea^87547
 ;;^UTILITY(U,$J,358.3,2036,0)
 ;;=492.8^^21^184^10
 ;;^UTILITY(U,$J,358.3,2036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2036,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,2036,1,5,0)
 ;;=5^Emphysema
 ;;^UTILITY(U,$J,358.3,2036,2)
 ;;=Emphysema^87569
 ;;^UTILITY(U,$J,358.3,2037,0)
 ;;=515.^^21^184^14
 ;;^UTILITY(U,$J,358.3,2037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2037,1,4,0)
 ;;=4^515.
 ;;^UTILITY(U,$J,358.3,2037,1,5,0)
 ;;=5^Interstitial Lung disease
 ;;^UTILITY(U,$J,358.3,2037,2)
 ;;=^101072
 ;;^UTILITY(U,$J,358.3,2038,0)
 ;;=786.52^^21^184^15
 ;;^UTILITY(U,$J,358.3,2038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2038,1,4,0)
 ;;=4^786.52
 ;;^UTILITY(U,$J,358.3,2038,1,5,0)
 ;;=5^Painful resp, Pleurodynia
 ;;^UTILITY(U,$J,358.3,2038,2)
 ;;=^89126
 ;;^UTILITY(U,$J,358.3,2039,0)
 ;;=511.0^^21^184^17
 ;;^UTILITY(U,$J,358.3,2039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2039,1,4,0)
 ;;=4^511.0
 ;;^UTILITY(U,$J,358.3,2039,1,5,0)
 ;;=5^Pleurisy
 ;;^UTILITY(U,$J,358.3,2039,2)
 ;;=Pleurisy^95432
 ;;^UTILITY(U,$J,358.3,2040,0)
 ;;=486.^^21^184^18
 ;;^UTILITY(U,$J,358.3,2040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2040,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,2040,1,5,0)
 ;;=5^Pneumonia, Unsp Organism
